Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre prospective study,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre prospective study
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-07-22 , DOI: 10.1111/apt.18165
Philippe Sultanik ₁ , Guillaume Lherault ₁ , Charlotte Bouzbib ₁ , Vlad Ratziu _{1,

2,

3} , Raluca Pais _{1,

2,

3} , Sarah Mouri ₁ , Dominique Thabut _{1,

2,

3} , Marika Rudler _{1,

2,

3}

Affiliation

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related cirrhosis has been increasing these last decades. There are no data regarding the prevalence of MASLD-related cirrhosis in intensive care unit (ICU).

中文翻译：